Ugur Sahin, CEO, and Özlem Türeci, CMO of BioNTech
July 26, 2022 01:43 PM EDT
Pharma
Coronavirus
Law

Pfiz­er and BioN­Tech hit back against Cure­Vac suit over Covid-19 vac­cine patents

Tyler Patchen

News Reporter

Af­ter its Covid-19 vac­cine can­di­date pe­tered out, Cure­Vac ear­li­er this month filed suit against BioN­Tech in Ger­man court, stat­ing that Cure­Vac should be com­pen­sat­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Bris­tol My­er­s' TYK2 in­hibitor suc­ceeds in pair of Phase 3 pso­ri­at­ic arthri­tis tri­als

A service from the Financial Times